Sitahenz DL 5mg/50mg Tablet

Przegląd produktu

About Sitahenz DL

Sitahenz DL is a medication containing the active ingredient Dapagliflozin, classified as Diabetes medication. Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. It is also used to treat adults with heart failure and chronic kidney disease.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE FARXIGA (dapagliflozin) is indicated: • To reduce the risk of sustained eGFR decline, end-stage kidney disease.
• Used for: • To reduce the risk of CV death, hospitalization for he…
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Dapagliflozin, the active ingredient in Sitahenz DL, belongs to the Diabetes medication class. 1 INDICATIONS AND USAGE FARXIGA (dapagliflozin) is indicated: • To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression. • To reduce the risk of CV death, hospitalization for he…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Sitahenz DL. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Sitahenz DL for extended periods without medical advice.